Tag: Alzheimer’s
Medicare Spending Spikes for Dementia Diagnoses in Seniors
Medicare spending higher for adults with a formal clinical diagnosis of dementia versus a positive screening for cognitive impairment
Prevalence of Risk Factors for Alzheimer, Related Dementias Identified
Highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity
Choroid Plexus Volume Up With Advanced Cognitive Impairment
Larger volume associated with severity of cognitive impairment across Alzheimer disease spectrum
One in Three Alzheimer, Dementia Cases Tied to Modifiable Risk Factors
Risk factors differ based on sex and race and ethnicity
FDA OKs Marketing of New Test to Help Diagnose Alzheimer Disease
Lumipulse G β-Amyloid Ratio (1-42/1-40) test is first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer disease
Interventions for Alzheimer Disease Improve Cognition in Men, Women
Individualized multidomain interventions equally effective for improving cognition in women, men
Race May Impact Accuracy of Models Predicting Brain Amyloidosis
Models using plasma Aβ42/Aβ40 to predict probability of CSF Aβ42/Aβ40 positivity not affected by race
DMARDs Not Linked to Alzheimer Risk for Seniors With RA
No reduction in ADRD risk seen for treatment with tofacitinib, tocilizumab, TNF inhibitors versus abatacept
Alzheimer Disease, Related Dementia Diagnoses Up in Medicare Decedents
Percentage of older U.S. decedents with a diagnosis of Alzheimer disease and related dementias increased significantly from 2004 to 2017
Excess Mortality Seen for Seniors With Alzheimer Disease, Dementia in COVID-19
Enrollees with ADRD had increased adjusted mortality, especially for Asian, Black, Hispanic populations with ADRD
